Subscribe
e.g. organoids

Allogeneic BCMA-Targeting CAR T Cells in Relapsed/Refractory Multiple Myeloma: Phase I UNIVERSAL Trial Interim Results

Investigators evaluated escalating doses of ALLO-715 after lymphodepletion with an anti-CD52 antibody (ALLO-647)-containing regimen in 43 patients with relapsed/refractory multiple myeloma.
[Nature Medicine]
AbstractPress Release
Published In
NewslettersCell Therapy News
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News

An mTurq2-Col4a1 Mouse Model Allows for Live Visualization of Mammalian Basement Membrane Development

[Journal Of Cell Biology] Using an innovative planar-sagittal live imaging technique to visualize the basement membrane of developing skin, researchers directly observed basement membrane deformation during hair follicle budding and basal progenitor cell divisions.
Dermal Cell NewsExtracellular Matrix NewsNewsletters
Read more

The Role of APOBEC3B in Lung Tumor Evolution and Targeted Cancer Therapy Resistance

[Nature Genetics] Scientists studied the impact of the apolipoprotein B mRNA-editing catalytic subunit-like (APOBEC) enzyme APOBEC3B on epidermal growth factor receptor-driven lung cancer.
NewslettersPulmonary Cell News
Read more

Ang-(1–7)/Mas Axis Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice via Restoration of Nox4-Nrf2 Redox Homeostasis

[European Journal Of Pharmacology] The angiotensin (Ang)-(1–7)-/Mas axis inhibited TGF-β1-induced lung fibroblast differentiation, inflammation, and fibrosis in bleomycin-treated lung tissue.
NewslettersPulmonary Cell News
Read more
Brought to you by